IM Cannabis Corp. (IMCC) stock
IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.49−0.00 (-0.26%)
Close on Nov 17, 2026Market cap $2.91MP/E –Yield –
IM Cannabis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was C$54.73M, up 1.3% from the year before. The highest annual figure on record is C$54.73M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | C$54.73M | +1.3% |
| FY2024 | Dec 31, 2024 | C$54.03M | +10.7% |
| FY2023 | Dec 31, 2023 | C$48.80M | -10.2% |
| FY2022 | Dec 31, 2022 | C$54.34M | +59.6% |
| FY2021 | Dec 31, 2021 | C$34.05M | +114.3% |
| FY2020 | Dec 31, 2020 | C$15.89M | +75.1% |
| FY2019 | Dec 31, 2019 | C$9.07M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | C$7.59M | -40.3% |
| Q2 FY2025 | Jun 30, 2025 | C$12.70M | +14.3% |
| Q2 FY2024 | Jun 30, 2024 | C$14.75M | – |
| Q2 FY2023 | Jun 30, 2023 | C$13.21M | – |
| Q2 FY2022 | Jun 30, 2022 | C$12.70M | – |
| Q2 FY2021 | Jun 30, 2021 | C$11.11M | – |
See a number that looks wrong?